Neuromyelitis Optica Therapeutics Market Size in the 7MM is anticipated to grow a significant CAGR by 2034, estimates DelveInsight | Bio-Thera Solutions, Reistone Biopharma Limited, TG Therapeutics

DelveInsight's "Neuromyelitis Optica Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Neuromyelitis Optica, historical and forecasted epidemiology as well as the neuromyelitis optica market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Discover which therapies are expected to grab the Neuromyelitis Optica Market Share @ Neuromyelitis Optica Market Outlook- https://www.delveinsight.com/sample-request/neuromyelitis-optica-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Neuromyelitis Optica Market Report
• In March 2025, Hoffmann-La Roche conducted a study will primarily evaluate the pharmacokinetics of satralizumab in pediatric patients aged 2-11 years with anti-aquaporin-4 (AQP4) antibody seropositive neuromyelitis optica spectrum disorder (NMOSD). Efficacy, safety, tolerability, and pharmacodynamics will be evaluated in a descriptive manner, given the small number of patients who will be enrolled in this study.
• In February 2025, Alexion Pharmaceuticals organized a study is to evaluate the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of Eculizumab in Chinese Adults with Neuromyelitis Optica Spectrum Disorders (NMOSD).
• According to the findings, neuromyelitis optica characteristically occurs in females and younger patients between 30 and 40 years of age. Pediatric cases of neuromyelitis optica are rare but have been reported occasionally.
• According to the findings, over 95% of neuromyelitis optica patients report no family history of the disease. Additionally, there is a strong association with a personal or family history of autoimmunity, which is present in 50% of cases.
• The leading Neuromyelitis Optica Companies such as Bio-Thera Solutions, Reistone Biopharma Limited, TG Therapeutics and others.
• Promising Neuromyelitis Optica Pipeline Therapies such as BAT4406F, SHR1459, Ublituzimab and others.

Stay ahead in the Neuromyelitis Optica Therapeutics Market with DelveInsight's Strategic Report @ Neuromyelitis Optica Market Outlook- https://www.delveinsight.com/sample-request/neuromyelitis-optica-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Neuromyelitis Optica Epidemiology Segmentation in the 7MM
• Total Neuromyelitis Optica Prevalent Cases
• Neuromyelitis Optica Diagnosed and treatable Cases
• Neuromyelitis Optica Gender-Specific Cases

Download the report to understand which factors are driving Neuromyelitis Optica Epidemiology trends @ Neuromyelitis Optica Prevalence- https://www.delveinsight.com/sample-request/neuromyelitis-optica-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Neuromyelitis Optica Marketed Drugs
• SOLIRIS (eculizumab): Alexion Pharmaceutical
In June 2019, the FDA approved SOLIRIS for the treatment of neuromyelitis optica spectrum disorder in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. It is the first drug specifically approved by the FDA specifically for neuromyelitis optica spectrum disorder. Eculizumab is an mAb that targets the C5 antibody. FDA granted Priority Review for the application of Soliris by Alexion Pharmaceuticals, expediting the approval of the drug.

• UPLIZNA (inebilizumab-cdon): Mitsubishi Chemical Group Corporation
The neuromyelitis optica spectrum disorder patients were offered an additional treatment option when the FDA approved a second drug, UPLIZNA injection for intravenous use, in adult patients with a particular antibody (patients who are anti-aquaporin-4 or AQP4 antibody positive). This drug was approved based on a clinical study of 230 adult patients that evaluated the efficacy and safety of intravenous Uplizna. During the 197-day study, the risk of an NMOSD relapse in the 161 anti-AQP4 antibody-positive patients who were treated with UPLIZNA was reduced by 77% when compared to the placebo treatment group.

Leber Hereditary Optic Neuropathy Drugs and Companies
• Bio-Thera Solutions: BAT4406F
• Reistone Biopharma Limited: SHR1459
• TG Therapeutics: Ublituzimab

To learn more about Neuromyelitis Optica treatment guidelines, visit @ Chr Neuromyelitis Optica Treatment Market Landscape- https://www.delveinsight.com/sample-request/neuromyelitis-optica-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Neuromyelitis Optica Treatment Market Landscape
The Neuromyelitis Optica treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Neuromyelitis Optica has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.

Scope of the Neuromyelitis Optica Market Report
• Coverage- 7MM
• Study Period- 2020-2034
• Neuromyelitis Optica Companies- Bio-Thera Solutions, Reistone Biopharma Limited, TG Therapeutics and others.
• Neuromyelitis Optica Pipeline Therapies- BAT4406F, SHR1459, Ublituzimab and others.
• Neuromyelitis Optica Market Dynamics: Neuromyelitis Optica Market Drivers and Barriers
• Neuromyelitis Optica Market Access and Reimbursement, Unmet Needs and Future Perspectives

Discover more about Neuromyelitis Optica Drugs in development @ Neuromyelitis Optica Clinical Trials Assessment- https://www.delveinsight.com/sample-request/neuromyelitis-optica-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Report Introduction
3. Neuromyelitis optica (NMO) Market Overview at a Glance
4. Executive Summary of Neuromyelitis optica (NMO)
5. Disease Background and Overview
6. Epidemiology and Patient Population
7. Marketed Drugs
8. Patient Journey
9. Market Outlook
10. Neuromyelitis optica (NMO) 7 Major Market Analysis
11. United States Market Size
12. EU-4 and the UK Market
13. Japan Market Size
14. SWOT Analysis
15. KOL Views
16. Appendix
17. DelveInsight Capabilities
18. Disclaimer
19. About DelveInsight

List of Top Selling Market Research Reports in 2025

Biopsy devices market- https://www.delveinsight.com/report-store/biopsy-devices-market
Diabetic wound market - https://www.delveinsight.com/report-store/diabetic-wounds-market
Joint reconstruction devices market- https://www.delveinsight.com/report-store/joint-reconstruction-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Cystic fibrosis market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Heart failure market- https://www.delveinsight.com/report-store/congestive-heart-failure-market
NK Cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Positive airway pressure device market - https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
Stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
Surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Thyroid cancer market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Urinary catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Uterine fibroids market- https://www.delveinsight.com/report-store/uterine-leiomyoma-uterine-fibroids-market
Attention deficit hyperactivity disorder adhd market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lice infestations market- https://www.delveinsight.com/report-store/lice-infestations-market
Lymphoedema market- https://www.delveinsight.com/report-store/lymphoedema-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/

This release was published on openPR.